Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

収録刊行物

  • Drug Safety

    Drug Safety 45 (8), 891-908, 2022-07-12

    Springer Science and Business Media LLC

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ